(Q51403215)

4 April 2018

title

gamma-aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine. (English)

1 reference

4 April 2018

1 reference

Gerasimov MR

1

1 reference

4 April 2018

Schiffer WK

2

1 reference

4 April 2018

Brodie JD

3

1 reference

4 April 2018

Lennon IC

4

1 reference

4 April 2018

Taylor SJ

5

1 reference

4 April 2018

Dewey SL

6

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 April 2000

1 reference

4 April 2018

European Journal of Pharmacology

published in

1 reference

4 April 2018

volume

395

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

page(s)

129-135

1 reference

4 April 2018

Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

(R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Inhibition of gamma-aminobutyrate and glycine uptake into synaptic vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

A novel strategy for the treatment of cocaine addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Effect of nucleus accumbens dopamine depletion on motivational aspects involved in initiation of cocaine and heroin self-administration in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

The effects of diazepam and zolpidem on cocaine- and amphetamine-induced place preference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Direct approach for attenuating cocaine's effects on extracellular dopamine: targeting the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Baclofen attenuates the reinforcing effects of cocaine in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Pharmacology of Vigabatrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900267-3

10.1016/S0014-2999(00)00267-3

7 January 2021

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018